Category: 6. Health

PATH and EuBiologics Co., LTD are pleased to announce Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.^® Multi-dose is manufactured by EuBiologics Co., LTD,…

Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published by The…

Headache disorders affected almost 3 billion people worldwide in 2023-nearly one in every three people, a figure unchanged since 1990-and ranked sixth among causes of health loss, according to new research to be published…

New research reveals how long work hours and high stress drain parents’ capacity to help with homework, widening gaps in children’s reading achievement and exposing a hidden cost of modern family life.

When work and worry…

Please chooseI’m not a medical professional.Allergy and ImmunologyAnatomyAnesthesiologyBiostatisticsCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency Medicine

By flipping a single genetic switch from APOE4 to APOE2 in adult mice, researchers reversed key Alzheimer’s-like changes in the brain while revealing the metabolic trade-offs that future APOE-targeted therapies must safely…

The rate of children and teenagers living with high blood pressure globally has nearly doubled because of a toxic combination of unhealthy diets, mass inactivity and soaring levels of obesity, according to the largest review of its kind.

Experts…

Please chooseI’m not a medical professional.Allergy and ImmunologyAnatomyAnesthesiologyBiostatisticsCardiac/Thoracic/Vascular SurgeryCardiologyCritical CareDentistryDermatologyDiabetes and EndocrinologyEmergency Medicine